IL136251A0 - Soft pellet drug composition and methods for the preparation thereof - Google Patents
Soft pellet drug composition and methods for the preparation thereofInfo
- Publication number
- IL136251A0 IL136251A0 IL13625198A IL13625198A IL136251A0 IL 136251 A0 IL136251 A0 IL 136251A0 IL 13625198 A IL13625198 A IL 13625198A IL 13625198 A IL13625198 A IL 13625198A IL 136251 A0 IL136251 A0 IL 136251A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- methods
- drug composition
- soft pellet
- pellet drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33322897 | 1997-12-03 | ||
| PCT/JP1998/005159 WO1999027911A1 (fr) | 1997-12-03 | 1998-11-16 | Medicament en pastilles souples et procede de fabrication |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL136251A0 true IL136251A0 (en) | 2001-05-20 |
Family
ID=18263764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13625198A IL136251A0 (en) | 1997-12-03 | 1998-11-16 | Soft pellet drug composition and methods for the preparation thereof |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1036562A1 (xx) |
| KR (1) | KR20010032303A (xx) |
| CN (1) | CN1283991A (xx) |
| AR (1) | AR015491A1 (xx) |
| AU (1) | AU1054399A (xx) |
| BR (1) | BR9815345A (xx) |
| CA (1) | CA2310826A1 (xx) |
| HU (1) | HUP0004821A2 (xx) |
| ID (1) | ID28057A (xx) |
| IL (1) | IL136251A0 (xx) |
| NO (1) | NO20002831L (xx) |
| NZ (1) | NZ504711A (xx) |
| PL (1) | PL340736A1 (xx) |
| TR (1) | TR200001596T2 (xx) |
| WO (1) | WO1999027911A1 (xx) |
| ZA (1) | ZA9810882B (xx) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6750324B1 (en) | 1997-12-02 | 2004-06-15 | Neuralab Limited | Humanized and chimeric N-terminal amyloid beta-antibodies |
| US6905686B1 (en) | 1997-12-02 | 2005-06-14 | Neuralab Limited | Active immunization for treatment of alzheimer's disease |
| US7790856B2 (en) | 1998-04-07 | 2010-09-07 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize beta amyloid peptide |
| US6787523B1 (en) | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
| TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
| US20030147882A1 (en) | 1998-05-21 | 2003-08-07 | Alan Solomon | Methods for amyloid removal using anti-amyloid antibodies |
| US6787637B1 (en) | 1999-05-28 | 2004-09-07 | Neuralab Limited | N-Terminal amyloid-β antibodies |
| UA81216C2 (en) | 1999-06-01 | 2007-12-25 | Prevention and treatment of amyloid disease | |
| US7807211B2 (en) | 1999-09-03 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of an implantable medical device |
| US6790228B2 (en) | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
| US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
| US7700751B2 (en) | 2000-12-06 | 2010-04-20 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize β-amyloid peptide |
| ITMI20012174A1 (it) * | 2001-10-18 | 2003-04-18 | Univ Parma | Polvere per somministrazione nasale di farmaci |
| MY139983A (en) | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
| EP1417958A1 (en) * | 2002-11-08 | 2004-05-12 | Pari GmbH | Wet granulation process |
| TWI374893B (en) | 2003-05-30 | 2012-10-21 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
| US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
| WO2005004875A1 (ja) * | 2003-07-14 | 2005-01-20 | Sankyo Company, Limited | 経肺投与用医薬組成物 |
| PE20061329A1 (es) | 2004-12-15 | 2006-12-08 | Neuralab Ltd | Anticuerpos ab humanizados para mejorar la cognicion |
| US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
| EP2124898B1 (en) * | 2007-01-10 | 2013-08-14 | Board of Regents, The University of Texas System | Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery |
| US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
| SI2182983T1 (sl) | 2007-07-27 | 2014-09-30 | Janssen Alzheimer Immunotherapy | Zdravljenje amiloidogenih bolezni s humaniziranimi protitelesi proti abeta |
| CN101969959A (zh) | 2007-07-31 | 2011-02-09 | 利默里克生物制药公司 | 磷酸化吡喃酮类似物和方法 |
| JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
| US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
| JP5872564B2 (ja) | 2011-09-14 | 2016-03-01 | 塩野義製薬株式会社 | 吸入用医薬組成物 |
| TWI745396B (zh) | 2016-07-12 | 2021-11-11 | 日商鹽野義製藥股份有限公司 | 吸入用醫藥組成物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9001635D0 (en) * | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
| JP2736168B2 (ja) * | 1992-03-10 | 1998-04-02 | フアイソンズ・ピーエルシー | 医薬製剤 |
| AU4066693A (en) * | 1992-12-23 | 1994-07-19 | Bernhard Hugemann | Compacted drug body for use in the mechanical generation of inhalable active-substance particles |
| JPH08291072A (ja) * | 1995-04-22 | 1996-11-05 | Kissei Pharmaceut Co Ltd | 吸入用粉末製剤用結晶とその製造方法 |
| JPH08291073A (ja) * | 1995-04-22 | 1996-11-05 | Kissei Pharmaceut Co Ltd | 医薬品組成物及びその製造方法 |
-
1998
- 1998-11-16 WO PCT/JP1998/005159 patent/WO1999027911A1/ja not_active Application Discontinuation
- 1998-11-16 PL PL98340736A patent/PL340736A1/xx unknown
- 1998-11-16 AU AU10543/99A patent/AU1054399A/en not_active Abandoned
- 1998-11-16 NZ NZ504711A patent/NZ504711A/en unknown
- 1998-11-16 CN CN98813464A patent/CN1283991A/zh active Pending
- 1998-11-16 EP EP98953072A patent/EP1036562A1/en not_active Withdrawn
- 1998-11-16 BR BR9815345-5A patent/BR9815345A/pt not_active Application Discontinuation
- 1998-11-16 ID IDW20001294A patent/ID28057A/id unknown
- 1998-11-16 HU HU0004821A patent/HUP0004821A2/hu unknown
- 1998-11-16 IL IL13625198A patent/IL136251A0/xx unknown
- 1998-11-16 TR TR2000/01596T patent/TR200001596T2/xx unknown
- 1998-11-16 KR KR1020007005513A patent/KR20010032303A/ko active IP Right Grant
- 1998-11-16 CA CA002310826A patent/CA2310826A1/en not_active Abandoned
- 1998-11-27 ZA ZA9810882A patent/ZA9810882B/xx unknown
- 1998-12-02 AR ARP980106105A patent/AR015491A1/es unknown
-
2000
- 2000-06-02 NO NO20002831A patent/NO20002831L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20002831D0 (no) | 2000-06-02 |
| KR20010032303A (ko) | 2001-04-16 |
| ID28057A (id) | 2001-05-03 |
| AR015491A1 (es) | 2001-05-02 |
| CN1283991A (zh) | 2001-02-14 |
| WO1999027911A1 (fr) | 1999-06-10 |
| PL340736A1 (en) | 2001-02-26 |
| NO20002831L (no) | 2000-08-03 |
| AU1054399A (en) | 1999-06-16 |
| BR9815345A (pt) | 2000-11-21 |
| EP1036562A1 (en) | 2000-09-20 |
| TR200001596T2 (tr) | 2000-12-21 |
| NZ504711A (en) | 2002-02-01 |
| HUP0004821A2 (hu) | 2001-06-28 |
| ZA9810882B (en) | 1999-05-26 |
| CA2310826A1 (en) | 1999-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL136251A0 (en) | Soft pellet drug composition and methods for the preparation thereof | |
| HUP0004398A3 (en) | Alpha-aryl-n-alkylnitrones and pharmaceutical compositions containing the same | |
| EP0943327A4 (en) | DRUG | |
| GB9706089D0 (en) | Pharmaceutical composition | |
| EP0978288A4 (en) | DRUG COMPOSITION | |
| HUP9802132A3 (en) | Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them | |
| HUP0101701A3 (en) | Substituted betha-alanines and pharmaceutical compositions comprising them | |
| IL117623A (en) | Maltitol composition and its preparation | |
| CZ2000522A3 (cs) | Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití | |
| GB9717444D0 (en) | Pharmaceutical composition | |
| IL140742A0 (en) | Raloxifene and pharmaceutical composition comprising the same | |
| PL330762A1 (en) | Pesticide preparation in the form of pellets | |
| HUP0002455A3 (en) | Gastric-retained pharmaceutical composition | |
| SG71754A1 (en) | Copolymer and copolymer composition | |
| GB9717428D0 (en) | Pharmaceutical composition | |
| HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
| IL122920A (en) | Castrointestinal drug composition | |
| GB9606579D0 (en) | Pharmaceutical composition and methods for the manufacture thereof | |
| EP0987942A4 (en) | PHARMACEUTICAL COMPOSITION AND METHOD OF USE | |
| AU7681498A (en) | Pharmaceutical composition and use thereof | |
| HUP0004132A3 (en) | Rapidly soluble drug composition | |
| GB9717770D0 (en) | Pharmaceutical composition | |
| GB2321190B (en) | Pharmaceutical composition | |
| GB9726781D0 (en) | Pharmaceutical composition | |
| HUP9903500A3 (en) | Thiophene-, furane- and pyrrolesulfonamides, their use and pharmaceutical compositions containing them |